Fintel reports that on January 16, 2025, Cantor Fitzgerald initiated coverage of Palantir Technologies (NasdaqGS:PLTR) with a ...

Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a ...

Cantor Fitzgerald reiterated their overweight rating on shares of Amicus Therapeutics (NASDAQ:FOLD – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $21.

Cantor Fitzgerald analyst Jonathan Ruykhaver raised the firm’s price target on CrowdStrike (CRWD) to $410 from $370 and keeps an Overweight ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main driver of the rating is the parent firm's five-year risk-adjusted success ratio of 90%. The measure ...

Cantor Fitzgerald analyst Sarah James initiated coverage with a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, commercial-stage biotechnology company with two approved ...

Tripadvisor Inc Common Stock (TRIP) stock saw a modest uptick, ending the day at $15.26 which represents a slight increase of $0.44 or 2.97% from the prior close of $14.82. The stock opened at $15.21 ...

and operational management Analyst Deepak Mathivanan from Cantor Fitzgerald increased Amazon’s (NASDAQ:AMZN) price target from $240 to $270 while keeping an Overweight rating. He shared a ...